Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2229-2240

  Oghumu, Steve ^a,b   Dong, Ran ^a   Varikuti, Sanjay ^a   Shawler, Todd ^b   Kampfrath, Thomas ^c   Terrazas, Cesar A ^a   Lezama Davila, Claudio ^a   Ahmer, Brian M M ^b   Whitacre, Caroline C ^b   Rajagopalan, Sanjay ^c   Locksley, Richard ^d   Sharpe, Arlene H ^e   Satoskar, Abhay R ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOSIS INHIBITOR; CELL PROTEIN; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GRANZYME B; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; PROTEIN LY6C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CXCR3 INTERNAL RIBOSOME ENTRY SITE BICISTRONIC ENHANCED GFP REPORTER MOUSE; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; HISTOPLASMOSIS; IN VIVO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; LEISHMANIASIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; WILD TYPE;

ANIMALS; ANTIGENS, LY; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; FOUNDER EFFECT; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; IMMUNITY, INNATE; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, VIDEO; RECEPTORS, CCR; RECEPTORS, CXCR3;

EID: 84874240213     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201170     Document Type: Article

References (33)

1. Groom, J. R., and A. D. Luster. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89: 207-215.
2. Carr, D. J., T. Wuest, and J. Ash. 2008. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J. Interferon Cytokine Res. 28: 245-251.
3. Rosas, L. E., J. Barbi, B. Lu, Y. Fujiwara, C. Gerard, V. M. Sanders, and A. R. Satoskar. 2005. CXCR32/2 mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur. J. Immunol. 35: 515-523.
4. Mohan, K., and T. B. Issekutz. 2007. Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis. J. Immunol. 179: 8463-8469.
5. Campanella, G. S., A. M. Tager, J. K. El Khoury, S. Y. Thomas, T. A. Abrazinski, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 105: 4814-4819.
6. Vandercappellen, J., J. Van Damme, and S. Struyf. 2008. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267: 226-244.
7. Mohrs, M., K. Shinkai, K. Mohrs, and R. M. Locksley. 2001. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15: 303-311.
8. Berg, L. J. 2007. Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development. Nat. Rev. Immunol. 7: 479-485.
9. Dubois, S., T. A. Waldmann, and J. R. Müller. 2006. ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc. Natl. Acad. Sci. USA 103: 12075-12080.
10. Hu, J., N. Sahu, E. Walsh, and A. August. 2007. Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk. Eur. J. Immunol. 37: 2892-2899.
11. Itsumi, M., Y. Yoshikai, and H. Yamada. 2009. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells. Eur. J. Immunol. 39: 1784-1793.
12. Cho, H., H. J. Choi, H. Xu, K. Felio, and C. R. Wang. 2011. Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3. J. Immunol. 186: 489-498.
13. Xu, H., N. A. DiIulio, and R. L. Fairchild. 1996. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J. Exp. Med. 183: 1001-1012.
14. Nakajima, C., T. Mukai, N. Yamaguchi, Y. Morimoto, W. R. Park, M. Iwasaki, P. Gao, S. Ono, H. Fujiwara, and T. Hamaoka. 2002. Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation. Eur. J. Immunol. 32: 1792-1801.
15. Belkaid, Y., E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168: 3992-4000.
16. Campanella, G. S., B. D. Medoff, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Development of a novel chemokine-mediated in vivo T cell recruitment assay. J. Immunol. Methods 331: 127-139.
17. Barbi, J., S. Oghumu, C. M. Lezama-Davila, and A. R. Satoskar. 2007. IFNgamma and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells. Blood 110: 2215-2216.
18. Uppaluri, R., K. C. Sheehan, L. Wang, J. D. Bui, J. J. Brotman, B. Lu, C. Gerard, W. W. Hancock, and R. D. Schreiber. 2008. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 86: 137-147.
19. Marques, C. P., P. Kapil, D. R. Hinton, C. Hindinger, S. L. Nutt, R. M. Ransohoff, T. W. Phares, S. A. Stohlman, and C. C. Bergmann. 2011. CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J. Virol. 85: 6136-6147.
20. Lord, G. M., R. M. Rao, H. Choe, B. M. Sullivan, A. H. Lichtman, F. W. Luscinskas, and L. H. Glimcher. 2005. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106: 3432-3439.
21. Dhanji, S., and H. S. Teh. 2003. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. J. Immunol. 171: 3442-3450.
22. Dhanji, S., M. T. Chow, and H. S. Teh. 2006. Self-antigen maintains the innate antibacterial function of self-specific CD8 T cells in vivo. J. Immunol. 177: 138-146.
23. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
24. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
25. Meiser, A., A. Mueller, E. L. Wise, E. M. McDonagh, S. J. Petit, N. Saran, P. C. Clark, T. J. Williams, and J. E. Pease. 2008. The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J. Immunol. 180: 6713-6724.
26. Liu, N., T. Phillips, M. Zhang, Y. Wang, J. T. Opferman, R. Shah, and P. G. Ashton-Rickardt. 2004. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5: 919-926.
27. Zhang, M., S. M. Park, Y. Wang, R. Shah, N. Liu, A. E. Murmann, C. R. Wang, M. E. Peter, and P. G. Ashton-Rickardt. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24: 451-461.
28. Allie, S. R., W. Zhang, S. Fuse, and E. J. Usherwood. 2011. Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection. J. Immunol. 186: 6280-6286.
29. Parish, I. A., and S. M. Kaech. 2009. Diversity in CD8(+) T cell differentiation. Curr. Opin. Immunol. 21: 291-297.
30. Hänninen, A., M. Maksimow, C. Alam, D. J. Morgan, and S. Jalkanen. 2011. Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. Eur. J. Immunol. 41: 634-644.
31. Carroll, H. P., V. Paunovic, and M. Gadina. 2008. Signalling, inflammation and arthritis: crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology (Oxford) 47: 1269-1277.
32. Miyazaki, T., Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Permutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231.
33. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6: 595-601.